NCT04376632

Brief Summary

Background: Previous studies report that daily pecan consumption reduces cholesterol in healthy adults while promoting weight maintenance. Purpose: To examine the impact of daily pecan consumption with and without dietary substitution instructions for an 8-week period on markers of health in adults at risk for cardiovascular disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 10, 2018

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

April 30, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 6, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

June 1, 2022

Status Verified

May 1, 2022

Enrollment Period

2.8 years

First QC Date

April 30, 2020

Last Update Submit

May 27, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in baseline fasting blood lipids at 4 weeks and 8 weeks

    Total cholesterol (mg/dL), high-density lipoprotein (HDL) cholesterol (mg/dL), triglycerides (mg/dL), low-density lipoprotein (LDL) cholesterol (mg/dL), non-HDL cholesterol (mg/dL), apolipoprotein B (mg/dL)

    Baseline, 4 weeks, 8 weeks

  • Change in baseline lipoprotein(a), lipoprotein particle number, and lipoprotein size at 4 and 8 weeks

    Low-density lipoprotein (LDL) particle number (nmol/L), LDL small (nmol/L), LDL medium (nmol/L), HDL large (nmol/L), lipoprotein(a) (nmol/L)

    Baseline, 4 weeks, 8 weeks

  • Change in baseline low-density lipoprotein (LDL) peak size at 4 and 8 weeks

    LDL peak size (angstrom)

    Baseline, 4 weeks, 8 weeks

  • Change in baseline weight at 4 and 8 weeks

    Weight (kg)

    Baseline, 4 weeks, 8 weeks

  • Change in baseline waist and hip circumference at 4 and 8 weeks

    waist and hip circumference (cm)

    Baseline, 4 weeks, 8 weeks

  • Change in baseline total body fat percentage at 4 and 8 weeks

    Total body fat percentage (%)

    Baseline, 4 weeks, 8 weeks

Secondary Outcomes (11)

  • Change in fasting and postprandial peptide YY, cholecystokinin (CCK), and ghrelin from baseline to 8 weeks

    Data will be collected at fasting at baseline, 4 weeks and 8 weeks. Postprandial data will be collected at baseline and 8 weeks.

  • Change in fasting and postprandial glucose and triglycerides from baseline to 8 weeks

    Data will be collected at fasting at baseline, 4 weeks and 8 weeks. Postprandial data will be collected at baseline and 8 weeks.

  • Change in fasting and postprandial non-esterified free fatty acids (NEFA) from baseline to 8 weeks

    Data will be collected at fasting at baseline, 4 weeks and 8 weeks. Postprandial data will be collected at baseline and 8 weeks.

  • Change in fasting and postprandial insulin from baseline to 8 weeks

    Data will be collected at fasting at baseline, 4 weeks and 8 weeks. Postprandial data will be collected at baseline and 8 weeks.

  • Change in resting metabolic rate (RMR) from baseline to 8 weeks

    Baseline and 8 weeks

  • +6 more secondary outcomes

Other Outcomes (1)

  • Change in baseline perceived stress at 4 and 8 weeks

    Baseline, 4 weeks, 8 weeks

Study Arms (3)

Control

NO INTERVENTION

Participants in this group avoid all nuts for 8 weeks.

Pecan ADD

EXPERIMENTAL

Participants in this group consume 68 g of pecans/d with no additional dietary instructions and avoid all other nuts.

Dietary Supplement: Pecan ADD

Pecan SUB

EXPERIMENTAL

Participants in this group consume 68 g of pecans/d with instructions to substitute pecans with isocaloric foods in the habitual diet. They are also instructed to avoid all other nuts.

Dietary Supplement: Pecan SUB

Interventions

Pecan ADDDIETARY_SUPPLEMENT

Raw pecan halves without dietary substitution instructions

Also known as: Pecan
Pecan ADD
Pecan SUBDIETARY_SUPPLEMENT

Raw pecan halves with instructions to substitute pecans with isocaloric foods in the habitual diet

Also known as: Pecan
Pecan SUB

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 30-75y with higher cholesterol levels or BMI of 28 kg/m2 or greater (A higher cholesterol level is indicated by "Borderline High/Undesirable" in two or more of the variables (total cholesterol 200-239 mg/dL, LDL cholesterol 130-159 mg/dL, triglycerides 150-199 mg/dL) or "High" in either total cholesterol (240 mg/dL and higher) or LDL (160 mg/dL or higher).

You may not qualify if:

  • Familial hypercholesterolemia (individuals with LDL levels greater than the 95th percentile or HDL levels lower than the 20th percentile based on age and sex)
  • Nut consumption \>2 servings/week or tree nut butter consumption \>3 servings/week
  • Hormone replacement therapy \<5 years
  • Women who are pregnant or planning to become pregnant
  • Regular exercise of \>3 hours/week
  • Weight gain or loss of \>5% of body weight during last 3 months
  • Plans to begin a weight loss/exercise regiment
  • History of medical or surgical events that could affect digestion or swallowing
  • Gastrointestinal surgeries, conditions or disorders
  • Chronic or metabolic diseases
  • Atherosclerosis, previous myocardial infarction, stroke, cancer
  • Fasting blood glucose levels \>126 mg/dl
  • Blood pressure \>180/120 mmHg
  • Medication use that affects digestion, absorption, metabolism
  • Lipid-lowering medications
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Georgia- Department of Foods and Nutrition

Athens, Georgia, 30605, United States

Location

Related Publications (1)

  • Guarneiri LL, Paton CM, Cooper JA. Pecan-Enriched Diets Alter Cholesterol Profiles and Triglycerides in Adults at Risk for Cardiovascular Disease in a Randomized, Controlled Trial. J Nutr. 2021 Oct 1;151(10):3091-3101. doi: 10.1093/jn/nxab248.

MeSH Terms

Conditions

HypercholesterolemiaObesity

Condition Hierarchy (Ancestors)

HyperlipidemiasDyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants are unaware that there are 2 pecan groups (with and without dietary substitution instructions)
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Dept. of Foods and Nutrition

Study Record Dates

First Submitted

April 30, 2020

First Posted

May 6, 2020

Study Start

August 10, 2018

Primary Completion

June 1, 2021

Study Completion

June 1, 2021

Last Updated

June 1, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

The plan is to share group averages through publication.

Locations